Reirradiation and teclistamab in relapsed multiple myeloma: initial experience in two heavily pretreated patients with extensive disease.

Nieder C, Hansen SU, Solhaug TS, Hallstensen RF.

Open source

DOI
10.5114/wo.2026.162045
Published
2026-05-27
Container
Contemp Oncol (Pozn)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5114/wo.2026.162045,
  title = {Reirradiation and teclistamab in relapsed multiple myeloma: initial experience in two heavily pretreated patients with extensive disease.},
  author = {Nieder C and  Hansen SU and  Solhaug TS and  Hallstensen RF.},
  year = {2026},
  journal = {Contemp Oncol (Pozn)},
  doi = {10.5114/wo.2026.162045},
  url = {https://doi.org/10.5114/wo.2026.162045}
}

RIS

TY  - JOUR
TI  - Reirradiation and teclistamab in relapsed multiple myeloma: initial experience in two heavily pretreated patients with extensive disease.
AU  - Nieder C
AU  -  Hansen SU
AU  -  Solhaug TS
AU  -  Hallstensen RF.
PY  - 2026
JO  - Contemp Oncol (Pozn)
DO  - 10.5114/wo.2026.162045
UR  - https://doi.org/10.5114/wo.2026.162045
ER  - 

APA

C, N., SU, H., TS, S., & RF., H. (2026). Reirradiation and teclistamab in relapsed multiple myeloma: initial experience in two heavily pretreated patients with extensive disease.. Contemp Oncol (Pozn). https://doi.org/10.5114/wo.2026.162045

Source records